Skin-cancer vaccine shows promise; America’s government debt passes $40trn, and more

皮肤癌疫苗展现出希望;美国国债突破40万亿美元,以及其他消息。

The World in Brief from The Economist

2026-08-20

4 分钟
PDF

单集简介 ...

Moderna and Merck, two American pharma companies, reported successful interim results in the trial of a personalised skin-cancer vaccine. Hosted on Acast. See acast.com/privacy for more information.
更多

单集文稿 ...

  • The Economist.

  • Top stories.

  • Moderna and Merck, two American pharma companies,

  • reported successful interim results in the trial of a personalized skin cancer vaccine.

  • The combination of an mRNA jab with an immunotherapy drug already produced by Merck.

  • Reduce melanoma reoccurrence.

  • The positive results are the first for a late-stage trial of an mRNA cancer vaccine.

  • Both companies' share prices rose.

  • Moderna's surged by 177%.

  • America's federal government debt passed $40 trillion for the first time, according to figures published on Wednesday.

  • Earlier, the Treasury said it will buy back more long-term government bonds in an attempt to contain borrowing costs.

  • In response, the yield on 30-year treasuries fell slightly to 5.2%.

  • Investors' worries about inflation and America's huge debt had pushed 30-year yields to their highest

  • since 2007. Donald Trump said he would meet Kim Jong-un, North Korea's dictator, this year.

  • Neither the White House nor the North Korean government confirmed this.

  • This week, Mr. Trump scaled back military exercises with South Korea,

  • partly because he has a, quote, very good relationship with Mr. Kim.

  • Despite the gesture, Kim Yo Jong, Mr. Kim's sister, said America still has a hostile policy towards North Korea.

  • Israel's military police launched criminal investigations into two incidents

  • in which Israel Defense Forces soldiers killed Palestinians in Gaza.